Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on January 12, 2012, covering an event that occurred on January 10, 2012. The filing discloses the Company's participation in the "Neurodegenerative Disease, Ophthalmology and Spinal Injury" panel at the 2012 Biotech Showcase in San Francisco, hosted by the Alliance for Regenerative Medicine.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a Regulation FD disclosure regarding a conference presentation and does not contain financial statements or operational metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing solely announces the Company's participation in a specific industry conference panel.
Guidance, Outlook, and Risks
The Company presented slides (Exhibit 99.01) at the conference, but the text of this 8-K does not summarize specific guidance, outlook, or management commentary contained within those slides. The filing includes a standard disclaimer stating that the information is not "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the registrant name is Neuralstem, Inc., not Palisade Bio, Inc.
- Review Exhibit 99.01 (Conference Slides) and Exhibit 99.02 (Press Release) for specific scientific or business updates not detailed in the 8-K text.
- Note that this filing is for disclosure purposes only and does not contain audited financial data.